Kiiskinen, Tuomo http://orcid.org/0000-0002-6306-8227
Mars, Nina J.
Palviainen, Teemu http://orcid.org/0000-0002-7847-8384
Koskela, Jukka http://orcid.org/0000-0002-0154-7222
Rämö, Joel T.
Ripatti, Pietari http://orcid.org/0000-0002-6530-3243
Ruotsalainen, Sanni
Palotie, Aarno
Madden, Pamela A. F.
Rose, Richard J.
Kaprio, Jaakko http://orcid.org/0000-0002-3716-2455
Salomaa, Veikko http://orcid.org/0000-0001-7563-5324
Mäkelä, Pia
Havulinna, Aki S.
Ripatti, Samuli
,
Article History
Received: 20 July 2019
Revised: 23 October 2019
Accepted: 14 November 2019
First Online: 21 January 2020
Conflict of interest
: A.P. reports that part of his salary is received from the FinnGen project that is partially funded by nine industry partners AbbVie, AstraZeneca, Biogen, Celgene, Genentech, GSK, Merck/MSD, Pfizer, and Sanofi. J.Ka. reports grants from Academy of Finland, US-PHS NIH/NIDA, US-PHS NIH/NIAAA, Pfizer Inc./GRAND program grant, and EU FP7 during the conduct of the study. V.S. reports a conference trip and an honorarium for participating in an advisory board meeting from Novo Nordisk (unrelated to the present study) and a grant to his institute for research collaboration from Bayer (unrelated to the present study). No other relationships or activities that could appear to have influenced the submitted work.